消化性潰瘍の世界市場レポート 2024

消化性潰瘍の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には3.5%の年間複合成長率（CAGR）で46億9,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、新たな治療法や治療法、高齢者人口の増加、精密医療の統合、予防措置、健康増進、進行中の調査や臨床試験によるものと考えられます。予測期間中に予想される注目すべき動向には、デジタルヘルスソリューション、治療法の進歩、ヘリコバクターピロリ感染の有病率の上昇、画像診断技術の統合、併用療法の利用増加などが含まれます。

予想される肥満有病率の増加は、消化性潰瘍市場の成長を促進する態勢が整っています。過剰な体脂肪の蓄積を特徴とする肥満は、通常、体格指数（BMI）が30以上になり、遺伝的、環境的、および不適切な食事や運動不足などのライフスタイル要因が原因である可能性があります。この状態は胃酸の産生の増加につながり、粘膜の保護機能を弱め、消化性潰瘍の発達に寄与します。さらに、過剰な体重は腸の炎症を促進し、消化性潰瘍のリスクをさらに高めます。特に、World Obesity Atlas 2022レポートでは、2020年の世界の肥満者数は7億6,400万人で、2025年までに8億9,200万人に達すると予測されており、消化性潰瘍市場における肥満の原動力が浮き彫りになっています。

喫煙率の上昇により、近い将来、消化性潰瘍市場の成長が促進されると予想されます。喫煙、つまりタバコやマリファナなどの植物由来製品の燃焼から出る蒸気の吸入は、消化性潰瘍疾患の原因となることが確立されています。喫煙は胃と十二指腸の内層に損傷を与え、胃への血液供給を減少させ、胃酸の生成を増加させるため、消化性潰瘍の発生率が上昇します。たとえば、2023年 6月のQuit Victoriaのデータは、14～17歳の現在の喫煙率が4年間で3倍に増加し、2022年には6.7%に達することを明らかにしました。その結果、喫煙率の上昇が消化性潰瘍市場の推進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の消化性潰瘍市場、疾患適応別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 胃炎
• 胃潰瘍
• 十二指腸潰瘍
• 胃食道逆流症（GERD）
• 世界の消化性潰瘍市場、薬剤タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• プロトンポンプ阻害剤（PPI）
• H2アンタゴニスト
• 抗生物質
• その他
• 世界の消化性潰瘍市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院薬局
• プライベートクリニック
• ドラッグストア
• 小売薬局
• eコマース

第7章 地域および国の分析

• 世界の消化性潰瘍市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の消化性潰瘍市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 消化性潰瘍市場の競合情勢
• 消化性潰瘍市場の企業プロファイル
  • Johnson &Johnson
  • Merck &Co. Inc.
  • AbbVie Inc.
  • Bayer AG
  • Novartis AG

第31章 その他の大手および革新的な企業

• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• CSL Limited
• Boehringer Ingelheim International GmbH
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Company
• Dr. Reddy's Laboratories Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

An open sore or raw area in the stomach lining or intestine is known as a peptic ulcer. It is primarily a result of the erosion of the protective lining of the stomach or the upper part of the small intestine, known as the duodenum. Common symptoms of peptic ulcers include upper abdominal pain or discomfort and symptoms of acid reflux, such as heartburn, sometimes accompanied by nausea.

The primary disease indications consist of gastritis, gastric ulcers, duodenal ulcers, and gastroesophageal reflux disease (GERD). Gastritis is a medical condition characterized by inflammation, irritation, or erosion of the stomach lining. The typical approach to treating gastritis involves medications such as proton pump inhibitors and lifestyle adjustments. The drugs utilized include proton pump inhibitors (PPI), H2 antagonists, antibiotics, and other pharmaceuticals, which are distributed through various channels such as hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce.

The peptic ulcer market research report is one of a series of new reports from The Business Research Company that provides peptic ulcer market statistics, including peptic ulcer industry global market size, regional shares, competitors with a peptic ulcer market share, detailed peptic ulcer market segments, market trends and opportunities, and any further data you may need to thrive in the peptic ulcer industry. This peptic ulcer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peptic ulcer market size has grown steadily in recent years. It will grow from $3.94 billion in 2023 to $4.1 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%. The growth observed in the historical period can be ascribed to several factors, including an increased prevalence of Helicobacter pylori infection, a rise in the use of nonsteroidal anti-inflammatory drugs (NSAIDs), shifts in lifestyles and dietary habits, awareness campaigns and educational initiatives, and a heightened focus on stress management.

The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $4.69 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The anticipated growth in the forecast period can be ascribed to emerging therapies and treatment modalities, a growing geriatric population, the integration of precision medicine, preventive measures, and health promotion, as well as ongoing research and clinical trials. Notable trends expected in the forecast period encompass digital health solutions, advancements in treatment modalities, a rising prevalence of Helicobacter pylori infection, the integration of diagnostic imaging technologies, and an increased utilization of combination therapies.

The anticipated rise in obesity prevalence is poised to drive the peptic ulcer market's growth. Obesity, characterized by excess body fat accumulation, typically results in a body mass index (BMI) of 30 or higher and can stem from genetic, environmental, and lifestyle factors such as poor diet and physical inactivity. This condition leads to increased stomach acid production, weakening the protective mucosal lining and contributing to peptic ulcer development. Moreover, excess weight promotes gut inflammation, further increasing the risk of peptic ulcers. Notably, the World Obesity Atlas 2022 report indicated that the global obesity estimate in 2020 was 764 million, projected to reach 892 million by 2025, underscoring the driving force of obesity on the peptic ulcer market.

The escalating rates of smoking are expected to fuel the peptic ulcer market's growth in the foreseeable future. Smoking, the inhalation of vapors from burning plant-based products such as tobacco or marijuana, is a well-established contributor to peptic ulcer disease. Smoking harms the stomach and duodenal linings, reduces blood supply to the stomach, and increases stomach acid production, elevating the incidence of peptic ulcers. For example, data from Quit Victoria in June 2023 highlighted a threefold increase in current cigarette smoking among 14-17-year-olds over four years, reaching 6.7% in 2022. Consequently, the rising smoking rates serve as a driving factor for the peptic ulcer market.

The substantial treatment costs represent a major impediment to the peptic ulcer market's growth during the forecast period. High treatment expenses for peptic ulcers pose a significant burden on patients, healthcare systems, and employers due to the costly medications administered in hospitals for complicated cases. As an illustration, information from the National Library of Medicine in February 2023 revealed that the annual cost of peptic ulcer disease in the USA is 5.65 billion USD, encompassing all medical expenditures. Consequently, the elevated treatment costs for peptic ulcers hinder the market's growth.

Companies engaged in the peptic ulcer market are actively developing innovative products and solutions, securing approval from regulatory agencies to gain a competitive edge. Drug development plays a pivotal role in managing and treating peptic ulcers, addressing symptom management, promoting healing, preventing complications, and treating underlying issues. Notably, in December 2021, the U.S. Food and Drug Administration granted approval to Dartisla ODT as the first medication specifically authorized for supplementing peptic ulcer disease treatment. Dartisla ODT, known for its anticholinergic properties, contains 1.7 mg of glycopyrrolate in each tablet.

In July 2022, Juvise Pharmaceuticals, a France-based pharmaceutical company, acquired the global commercial rights to Pylera from AbbVie Inc. for $408 million (€400 million). Pylera, an antimicrobial tri-therapy, targets peptic ulcers caused by Helicobacter pylori (H. pylori) infection. This acquisition is expected to facilitate Juvise Pharmaceuticals' expansion of its gastro-intestinal medicine product portfolio, serving as a strategic addition for geographic expansion. AbbVie Inc., a U.S.-based pharmaceutical company, specializes in providing various medications for diverse conditions, including peptic ulcers.

Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

North America was the largest region in the peptic ulcer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptic ulcer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The peptic ulcer market consists of revenues earned by entities by providing treatment services related to peptic ulcer such as surgeries, endoscopy, blood tests, and physical exams. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptic ulcer market also includes sales of acid blockers, cytoprotective agents, bismuth subsalicylate, and mastic powder. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peptic Ulcer Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptic ulcer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peptic ulcer? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptic ulcer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Disease Indication: Gastritis; Gastric Ulcer; Duodenal Ulcer; Gastroesophageal Reflux Disease (GERD)
• 2) By Drug Type: Proton Pump Inhibitors (PPI); H2 Antagonists; Antibiotics; Other Drugs
• 3) By Distribution Channel: Hospital Pharmacies; Private Clinics; Drug Store; Retail Pharmacies; E-commerce
• Companies Mentioned: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peptic Ulcer Market Characteristics

3. Peptic Ulcer Market Trends And Strategies

4. Peptic Ulcer Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Peptic Ulcer Market Size and Growth

• 5.1. Global Peptic Ulcer Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Peptic Ulcer Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Peptic Ulcer Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Peptic Ulcer Market Segmentation

• 6.1. Global Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Gastritis
• Gastric Ulcer
• Duodenal Ulcer
• Gastroesophageal Reflux Disease (GERD)
• 6.2. Global Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Proton Pump Inhibitors (PPI)
• H2 Antagonists
• Antibiotics
• Other Drug Types
• 6.3. Global Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Private Clinics
• Drug Store
• Retail Pharmacies
• E-commerce

7. Peptic Ulcer Market Regional And Country Analysis

• 7.1. Global Peptic Ulcer Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Peptic Ulcer Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Peptic Ulcer Market

• 8.1. Asia-Pacific Peptic Ulcer Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Peptic Ulcer Market

• 9.1. China Peptic Ulcer Market Overview
• 9.2. China Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Peptic Ulcer Market

• 10.1. India Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Peptic Ulcer Market

• 11.1. Japan Peptic Ulcer Market Overview
• 11.2. Japan Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Peptic Ulcer Market

• 12.1. Australia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Peptic Ulcer Market

• 13.1. Indonesia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Peptic Ulcer Market

• 14.1. South Korea Peptic Ulcer Market Overview
• 14.2. South Korea Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Peptic Ulcer Market

• 15.1. Western Europe Peptic Ulcer Market Overview
• 15.2. Western Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Peptic Ulcer Market

• 16.1. UK Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Peptic Ulcer Market

• 17.1. Germany Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Peptic Ulcer Market

• 18.5. France Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Peptic Ulcer Market

• 19.9. Italy Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Peptic Ulcer Market

• 20.13. Spain Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Peptic Ulcer Market

• 21.1. Eastern Europe Peptic Ulcer Market Overview
• 21.2. Eastern Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Peptic Ulcer Market

• 22.1. Russia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Peptic Ulcer Market

• 23.1. North America Peptic Ulcer Market Overview
• 23.2. North America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Peptic Ulcer Market

• 24.1. USA Peptic Ulcer Market Overview
• 24.2. USA Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Peptic Ulcer Market

• 25.1. Canada Peptic Ulcer Market Overview
• 25.2. Canada Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Peptic Ulcer Market

• 26.1. South America Peptic Ulcer Market Overview
• 26.2. South America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Peptic Ulcer Market

• 27.1. Brazil Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Peptic Ulcer Market

• 28.1. Middle East Peptic Ulcer Market Overview
• 28.2. Middle East Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Peptic Ulcer Market

• 29.1. Africa Peptic Ulcer Market Overview
• 29.2. Africa Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Peptic Ulcer Market Competitive Landscape And Company Profiles

• 30.1. Peptic Ulcer Market Competitive Landscape
• 30.2. Peptic Ulcer Market Company Profiles
  • 30.2.1. Johnson & Johnson
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck & Co. Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Peptic Ulcer Market Other Major And Innovative Companies

• 31.1. Sanofi S.A
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. CSL Limited
• 31.11. Boehringer Ingelheim International GmbH
• 31.12. Eisai Co. Ltd.
• 31.13. Sun Pharmaceutical Industries Ltd.
• 31.14. Otsuka Pharmaceutical Company
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Peptic Ulcer Market Competitive Benchmarking

33. Global Peptic Ulcer Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Peptic Ulcer Market

35. Peptic Ulcer Market Future Outlook and Potential Analysis

• 35.1 Peptic Ulcer Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Peptic Ulcer Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Peptic Ulcer Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer